September 4, 2025 · Form 4 insider transaction
Matsuda Masaru sold 36,130 shares of Arcutis Biotherapeutics, Inc. at $16.16 per share, a transaction worth $583.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026.; The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.93 to $16.3787, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.